Courtney Solberg | Manager of Corporate Communications & Investor Relations |
Nancy Simonian | Chief Executive Officer |
David Roth | Chief Medical Officer |
Jason Haas | Chief Financial Officer |
Phil Nadeau | Cowen & Company |
Jason Butler | JMP Securities |
Mark Breidenbach | Oppenheimer |
Good morning, and welcome to Syros Pharmaceuticals Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the Investor Relations and Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. At this time, I would like to turn the call over to Courtney Solberg, Manager of Corporate Communications and Investor Relations at Syros.